Your browser doesn't support javascript.
loading
Euglycemic diabetic ketoacidosis with canagliflozin: Not-so-sweet but avoidable complication of sodium-glucose cotransporter-2 inhibitor use.
Clement, Maureen; Senior, Peter.
  • Clement M; Clinical Assistant Professor at the University of British Columbia in Vancouver, a family physician with a consulting practice in diabetes in the interior of British Columbia, and Medical Lead for the Interior Health Authority Diabetes Strategy. maureen.clement@interiorhealth.ca.
  • Senior P; Professor, Director of the Division of Endocrinology and Metabolism, and Medical Director of the Clinical Islet Transplant Program at the University of Alberta in Edmonton.
Can Fam Physician ; 62(9): 725-8, 2016 Sep.
Article en En | MEDLINE | ID: mdl-27629668
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Cetoacidosis Diabética / Diabetes Mellitus Tipo 2 / Canagliflozina / Inhibidores del Cotransportador de Sodio-Glucosa 2 / Hipoglucemiantes Límite: Adult / Female / Humans Idioma: En Año: 2016 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Cetoacidosis Diabética / Diabetes Mellitus Tipo 2 / Canagliflozina / Inhibidores del Cotransportador de Sodio-Glucosa 2 / Hipoglucemiantes Límite: Adult / Female / Humans Idioma: En Año: 2016 Tipo del documento: Article